Pioglitazone
- Product NDC
- 68071-1621
- 11-digit product format
- 680711621
- Labeler code
- 68071
- Product ID
- 68071-1621_bb11f412-7d6c-2b4d-e053-2995a90abb56
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- pioglitazone
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- NuCare Pharmaceuticals,Inc.
- Application
- NDA021073
- Marketing category
- NDA AUTHORIZED GENERIC
- Marketing start
- 2012-08-17
- Marketing end
- 0000-00-00
- Substance
- PIOGLITAZONE HYDROCHLORIDE
- Active strength
- 30 mg/1
- Pharmacologic classes
- Peroxisome Proliferator-activated Receptor Activity [MoA],PPAR alpha [CS],PPAR gamma [CS],Thiazolidinedione [EPC],Thiazolidinediones [CS],Peroxisome Proliferator Receptor alpha Agonist [EPC],Peroxisome Proliferator Receptor gamma Agonist [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2022-12-31
- Current FDA listing
- Historical FDA.report record
FDA-Initiated Inactive NDC Indexing#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 68071-1621-3 | 68071162103 | 30 TABLET in 1 BOTTLE (68071-1621-3) | 30 tablet | 2017-08-08 | 0000-00-00 | No | No | Current |